Elon Musk announces Neuralink breakthrough, calling it 'big deal'; says: I am confident that ...

Elon Musk has announced a major Neuralink Breakthrough. The Billionaire said that his brain-computer interface company Neuralink can possibly restore full body functionality. Elon Musk's brain implant company Neuralink will start "high-volume production" of brain-computer interface devices and move to an entirely automated surgical procedure in 2026, Musk said in a post on the social media platform X on Wednesday. “I am confident at this point that restoring full body functionality is possible with Neuralink,” the Tesla and SpaceX founder said in a post on the social media platform X, formerly Twitter. “Neuralink can essentially help bridge communications from the cortex, past the point in the neck or spine, where the nerves are damaged. It is possible from a physics standpoint to physically restore full body functionality,” he said in a video post.

The breakthrough focuses on the motor cortex, restoring “full body functionality” for people with severed spinal cords. The motor cortex technology feature was first announced by Elon Musk in 2022, and the testing began in humans in the same year. According to Musk, any device that can be controlled via computer or phone can be controlled by a Neuralink implant.


The device includes a chip that replaces a small piece of bone and is connected to the brain via a series of thin, threaded electrodes. The company's N1 implant includes 1,024 electrodes distributed among 64 threads, according to the company's website. “Neuralink will start high-volume production of brain-computer interface devices and move to a streamlined, almost entirely automated surgical procedure in 2026. Device threads will go through the dura without the need to remove it. This is a big deal,” he shared on X.

Neuralink eyes mass brain implant production in 2026

In September 2025, Neuralink announced that it had implanted its device in 12 patients. The year 2025 also saw Neuralink raising $650 million in Series E funding, led by investors including ARK Invest, Sequoia Capital, and Founders Fund, valuing the company at approximately $9 billion.

On January 1 this year, Musk's California-based neurotechnology company announced taking major steps toward restoring vision, with a brain implant that allows the visually impaired, even those blind from birth.

Elon Musk thanks FDA for Blindsight

Blindsight, Neuralink’s brain chip aimed at restoring vision, received “breakthrough device” designation from the US Food and Drug Administration (FDA) in September 2024. The company is expected to begin high-volume production of the device this year.

Elon Musk said that Blindsight will help people who have lost both eyes, and they will be able to see. He also claimed that, provided the visual cortex remains intact, the device can restore vision even in people who have been blind since birth. "Blindsight will enable those who have total loss of vision, including if they've lost their eyes or the optic nerve, or maybe have never seen, or even blind from birth, to be able to see again," said Musk. Thanking US-FDA, Musk wrote, "To set expectations correctly, the vision will be at first be low resolution, like Atari graphics, but eventually it has the potential be better than natural vision and enable you to see in infrared, ultraviolet or even radar wavelengths, like Geordi La Forge. Much appreciated, @US_FDA."